ARCELLX INC's ticker is and the CUSIP is 03940C100. A total of 138 filers reported holding ARCELLX INC in Q3 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $162,800,189 | +9.8% | 4,537,352 | -3.3% | 0.01% | +16.7% |
| Q2 2023 | $148,329,357 | -10.3% | 4,690,998 | -12.6% | 0.01% | +50.0% |
| Q1 2023 | $165,332,004 | +312.5% | 5,366,180 | +314.8% | 0.01% | +100.0% |
| Q4 2022 | $40,075,728 | +170.7% | 1,293,600 | +64.0% | 0.00% | +100.0% |
| Q3 2022 | $14,803,000 | +31.3% | 788,668 | +26.4% | 0.00% | +100.0% |
| Q2 2022 | $11,277,000 | – | 623,718 | +4797730.8% | 0.00% | – |
| Q1 2022 | $0 | – | 13 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 5,500,007 | $169,455,216 | 63.12% |
| NEA Management Company, LLC | 4,745,262 | $146,201,522 | 10.11% |
| Samsara BioCapital, LLC | 909,579 | $28,024,129 | 5.79% |
| Paradigm Biocapital Advisors LP | 1,757,779 | $54,157,171 | 5.13% |
| Soleus Capital Management, L.P. | 1,248,147 | $38,455,409 | 3.98% |
| Perceptive Advisors | 3,841,739 | $118,363,979 | 3.50% |
| Cormorant Asset Management, LP | 1,600,000 | $49,296 | 3.25% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,398,321 | $73,892,270 | 3.12% |
| Altium Capital Management LP | 150,000 | $4,621,500 | 2.56% |
| Novo Holdings A/S | 1,225,000 | $37,742,250 | 2.49% |